A proper schedule of weekly paclitaxel and gemcitabine combination is highly active and very well tolerated in NSCLC patients

Autor: De Pas, Tommaso, Putzu, Carlo, Curigliano, Giuseppe, Noberasco, Cristina, Sabrina, Boselli, Catania, Chiara, Orlando, Laura, Milani, Alessandra, Spaggiari, Lorenzo, de Braud, Filippo
Zdroj: In Lung Cancer 2006 54(3):359-364
Databáze: ScienceDirect